{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:42Z","timestamp":1791176802710,"version":"4.1.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Premature atherosclerosis is a severe complication of lupus and other systemic autoimmune disorders. Gain-of-function polymorphisms in IFN regulatory factor 5 (IRF5) are associated with an increased risk of developing lupus, and IRF5 deficiency in lupus mouse models ameliorates disease. However, whether IRF5 deficiency also protects against atherosclerosis development in lupus is not known. In this study, we addressed this question using the gld.apoE\u2212\/\u2212 mouse model. IRF5 deficiency markedly reduced lupus disease severity. Unexpectedly, despite the reduction in systemic immune activation, IRF5-deficient mice developed increased atherosclerosis and also exhibited metabolic dysregulation characterized by hyperlipidemia, increased adiposity, and insulin resistance. Levels of the atheroprotective cytokine IL-10 were reduced in aortae of IRF5-deficient mice, and in vitro studies demonstrated that IRF5 is required for IL-10 production downstream of TLR7 and TLR9 signaling in multiple immune cell types. Chimera studies showed that IRF5 deficiency in bone marrow\u2013derived cells prevents lupus development and contributes in part to the increased atherosclerosis. Notably, IRF5 deficiency in non\u2013bone marrow\u2013derived cells also contributes to the increased atherosclerosis through the generation of hyperlipidemia and increased adiposity. Together, our results reveal a protective role for IRF5 in lupus-associated atherosclerosis that is mediated through the effects of IRF5 in both immune and nonimmune cells. These findings have implications for the proposed targeting of IRF5 in the treatment of autoimmune disease as global IRF5 inhibition may exacerbate cardiovascular disease in these patients.<\/jats:p>","DOI":"10.4049\/jimmunol.1402807","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T10:44:08Z","timestamp":1421491448000},"page":"1467-1479","source":"Crossref","is-referenced-by-count":55,"title":["IRF5 Deficiency Ameliorates Lupus but Promotes Atherosclerosis and Metabolic Dysfunction in a Mouse Model of Lupus-Associated Atherosclerosis"],"prefix":"10.1093","volume":"194","author":[{"given":"Amanda A","family":"Watkins","sequence":"first","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella E","family":"Wilson","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Aprahamian","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Maganto-Garcia","sequence":"additional","affiliation":[{"name":"Vascular Research Division, Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Shukla","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Oberlander","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bari","family":"Laskow","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanni","family":"Menn-Josephy","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Endocrinology Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K","family":"Fried","sequence":"additional","affiliation":[{"name":"Endocrinology Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Lichtman","sequence":"additional","affiliation":[{"name":"Vascular Research Division, Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon G","family":"Bonegio","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R","family":"Rifkin","sequence":"additional","affiliation":[{"name":"Renal Section, Department of Medicine, Boston University School of Medicine , Boston, MA 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,15]]},"reference":[{"key":"2025030705060405100_r1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat. Med."},{"key":"2025030705060405100_r2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE\u2014mechanisms and management","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2025030705060405100_r3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/0961203313493031","article-title":"Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?","volume":"22","author":"Nikpour","year":"2013","journal-title":"Lupus"},{"key":"2025030705060405100_r4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-med-060911-090007","article-title":"Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus","volume":"64","author":"Kahlenberg","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"2025030705060405100_r5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2025030705060405100_r6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1160\/TH11-05-0330","article-title":"The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity","volume":"106","author":"Wade","year":"2011","journal-title":"Thromb. Haemost."},{"key":"2025030705060405100_r7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20031557","article-title":"Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease","volume":"199","author":"Aprahamian","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025030705060405100_r8","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"Stanic","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/ATVBAHA.107.142430","article-title":"Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice","volume":"27","author":"Gautier","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r10","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2025030705060405100_r11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"2025030705060405100_r12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"2025030705060405100_r13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","author":"Mason","year":"2014","journal-title":"Eur. Heart J."},{"key":"2025030705060405100_r14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clim.2014.06.001","article-title":"IRF5-mediated signaling and implications for SLE","volume":"153","author":"Lazzari","year":"2014","journal-title":"Clin. Immunol."},{"key":"2025030705060405100_r15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/hmg\/ddu455","article-title":"The IRF5\u2013TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share","volume":"24","author":"Kottyan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2025030705060405100_r16","doi-asserted-by":"crossref","first-page":"23382","DOI":"10.1074\/jbc.M101216200","article-title":"Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes","volume":"276","author":"Barnes","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025030705060405100_r17","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/MCB.22.16.5721-5740.2002","article-title":"Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes","volume":"22","author":"Barnes","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"2025030705060405100_r18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","article-title":"Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors","volume":"434","author":"Takaoka","year":"2005","journal-title":"Nature"},{"key":"2025030705060405100_r19","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling","volume":"280","author":"Schoenemeyer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2025030705060405100_r20","doi-asserted-by":"crossref","first-page":"e1000500","DOI":"10.1371\/journal.ppat.1000500","article-title":"NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis","volume":"5","author":"Pandey","year":"2009","journal-title":"PLoS Pathog."},{"key":"2025030705060405100_r21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.immuni.2013.05.010","article-title":"Interferon-\u03b2 production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans","volume":"38","author":"del Fresno","year":"2013","journal-title":"Immunity"},{"key":"2025030705060405100_r22","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1073\/pnas.0712295105","article-title":"A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis","volume":"105","author":"Couzinet","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r23","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1074\/jbc.M804744200","article-title":"IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway","volume":"284","author":"Hu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025030705060405100_r24","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1073\/pnas.0611559104","article-title":"Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression","volume":"104","author":"Yanai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ni.2307","article-title":"Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses","volume":"13","author":"Negishi","year":"2012","journal-title":"Nat. Immunol."},{"key":"2025030705060405100_r26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat. Immunol."},{"key":"2025030705060405100_r27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.0901748","article-title":"IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-\/-Yaa and FcgammaRIIB-\/- mouse models of systemic lupus erythematosus","volume":"184","author":"Richez","year":"2010","journal-title":"J. Immunol."},{"key":"2025030705060405100_r28","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1073\/pnas.1005599107","article-title":"Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus","volume":"107","author":"Savitsky","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.30183","article-title":"Interferon regulatory factor 5 is critical for the development of lupus in MRL\/lpr mice","volume":"63","author":"Tada","year":"2011","journal-title":"Arthritis Rheum."},{"key":"2025030705060405100_r30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/eji.201141642","article-title":"Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching","volume":"42","author":"Feng","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"2025030705060405100_r31","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.4049\/jimmunol.1103113","article-title":"Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus","volume":"188","author":"Xu","year":"2012","journal-title":"J. Immunol."},{"key":"2025030705060405100_r32","doi-asserted-by":"crossref","first-page":"e103478","DOI":"10.1371\/journal.pone.0103478","article-title":"Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL\/lpr mouse model of lupus in the absence of a mutation in DOCK2","volume":"9","author":"Yasuda","year":"2014","journal-title":"PLoS ONE"},{"key":"2025030705060405100_r33","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2013.11.023","article-title":"In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing","volume":"63","author":"Courties","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"2025030705060405100_r34","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.177.5.3028","article-title":"Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model","volume":"177","author":"Aprahamian","year":"2006","journal-title":"J. Immunol."},{"key":"2025030705060405100_r35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4049\/jimmunol.182.1.340","article-title":"The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin","volume":"182","author":"Aprahamian","year":"2009","journal-title":"J. Immunol."},{"key":"2025030705060405100_r36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"key":"2025030705060405100_r37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","article-title":"Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease","volume":"9","author":"Cohen","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"2025030705060405100_r38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4049\/jimmunol.133.1.227","article-title":"Induction of various autoantibodies by mutant gene lpr in several strains of mice","volume":"133","author":"Izui","year":"1984","journal-title":"J. Immunol."},{"key":"2025030705060405100_r39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"2025030705060405100_r40","doi-asserted-by":"crossref","first-page":"E898","DOI":"10.1073\/pnas.1118155109","article-title":"Spontaneous mutation of the Dock2 gene in Irf5-\/- mice complicates interpretation of type I interferon production and antibody responses","volume":"109","author":"Purtha","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/intimm\/dxs114","article-title":"Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2","volume":"25","author":"Yasuda","year":"2013","journal-title":"Int. Immunol."},{"key":"2025030705060405100_r42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025030705060405100_r43","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."},{"key":"2025030705060405100_r44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1074-7613(00)80020-5","article-title":"Cathepsin S required for normal MHC class II peptide loading and germinal center development","volume":"10","author":"Shi","year":"1999","journal-title":"Immunity"},{"key":"2025030705060405100_r45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"2025030705060405100_r46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"2025030705060405100_r47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"2025030705060405100_r48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity"},{"key":"2025030705060405100_r49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2025030705060405100_r50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"2025030705060405100_r51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"2025030705060405100_r52","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.106.131755","article-title":"Adipose tissue and atherosclerosis: exploring the connection","volume":"27","author":"Fantuzzi","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025030705060405100_r54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"2025030705060405100_r55","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1182\/blood-2010-01-263020","article-title":"IRF5 is required for late-phase TNF secretion by human dendritic cells","volume":"115","author":"Krausgruber","year":"2010","journal-title":"Blood"},{"key":"2025030705060405100_r56","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/art.33395","article-title":"Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2025030705060405100_r57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2007.11.002","article-title":"Interferon regulatory factors are transcriptional regulators of adipogenesis","volume":"7","author":"Eguchi","year":"2008","journal-title":"Cell Metab."},{"key":"2025030705060405100_r58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"2025030705060405100_r59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"2025030705060405100_r61","doi-asserted-by":"crossref","first-page":"32950","DOI":"10.1074\/jbc.M109.040899","article-title":"Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages","volume":"284","author":"Han","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025030705060405100_r62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.ATV.0000134378.86443.cd","article-title":"Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice","volume":"24","author":"Potteaux","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r63","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCULATIONAHA.111.067678","article-title":"Toll-like receptor 7 protects from atherosclerosis by constraining \u201cinflammatory\u201d macrophage activation","volume":"126","author":"Salagianni","year":"2012","journal-title":"Circulation"},{"key":"2025030705060405100_r64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/ATVBAHA.113.302407","article-title":"Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"34","author":"Koulis","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r65","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r66","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","article-title":"Modulation of atherosclerosis in mice by Toll-like receptor 2","volume":"115","author":"Mullick","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025030705060405100_r67","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1073\/pnas.1018515108","article-title":"Unexpected protective role for Toll-like receptor 3 in the arterial wall","volume":"108","author":"Cole","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030705060405100_r68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tips.2013.09.008","article-title":"Toll-like receptors in atherosclerosis: a \u2018Pandora\u2019s box\u2019 of advances and controversies","volume":"34","author":"Cole","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"2025030705060405100_r69","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.178.11.6876","article-title":"Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production","volume":"178","author":"Yasuda","year":"2007","journal-title":"J. Immunol."},{"key":"2025030705060405100_r70","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1074\/jbc.M800501200","article-title":"Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response","volume":"283","author":"Paun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2025030705060405100_r71","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","article-title":"Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis","volume":"125","author":"D\u00f6ring","year":"2012","journal-title":"Circulation"},{"key":"2025030705060405100_r72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/ATVBAHA.111.224873","article-title":"Apoptotic cell death and efferocytosis in atherosclerosis","volume":"32","author":"Van Vr\u00e9","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025030705060405100_r73","doi-asserted-by":"crossref","first-page":"III2","DOI":"10.1161\/01.CIR.0000131511.50734.44","article-title":"Atherogenic lipoprotein particles in atherosclerosis","volume":"109","author":"Carmena","year":"2004","journal-title":"Circulation"},{"key":"2025030705060405100_r74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","article-title":"Metabolic syndrome: a clinical and molecular perspective","volume":"56","author":"Moller","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"2025030705060405100_r75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"2025030705060405100_r76","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00019.2011","article-title":"Role of the gut in lipid homeostasis","volume":"92","author":"Abumrad","year":"2012","journal-title":"Physiol. Rev."},{"key":"2025030705060405100_r77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2164-13-450","article-title":"Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity","volume":"13","author":"Kwon","year":"2012","journal-title":"BMC Genomics"},{"key":"2025030705060405100_r78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1172\/JCI38388","article-title":"Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice","volume":"120","author":"Wueest","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025030705060405100_r79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tem.2013.07.001","article-title":"On the TRAIL of obesity and diabetes","volume":"24","author":"Harith","year":"2013","journal-title":"Trends Endocrinol. Metab."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/4\/1467\/62236807\/1402807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/4\/1467\/62236807\/1402807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:28:55Z","timestamp":1741328935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/194\/4\/1467\/7961023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1402807","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2]]}}}